Articles From: The Medicines Company Reports Fourth Quarter and Full Year 2014 Financial Results to CollabRx Regains Compliance on Bid Price


2015/2/18
The Medicines Company (NASDAQ:MDCO) today announced fourth quarter and full year financial results for 2014.
Sign-up for The Medicines Company Reports Fourth Quarter and Full Year 2014 Financial Results investment picks
2015/2/18
HOUSTON , Feb.
Sign-up for Flotek Industries Announces Presentation at EnerCom's The Oil & Services Conference™ investment picks
2015/2/18
Anticipates End to System Support Resource Payments for All Consumers CLEVELAND , Feb.
Sign-up for Cliffs Natural Resources Inc. Finalizes Energy Agreement in U.P. of Michigan investment picks
2015/2/18
PLANO, Texas , Feb.
Sign-up for Monogram Residential Trust, Inc. Declares First Quarter 2015 Dividend investment picks
2015/2/18
G&K Services, Inc. (NASDAQ: GK) announced today the renewed sponsorship of JD Motorsports’ lead driver Landon Cassill and the No.
Sign-up for G&K Services Returns as Sponsor of JD Motorsports’ Landon Cassill in the 2015 NASCAR® Season investment picks
2015/2/18
RESEARCH TRIANGLE PARK, N.C., Feb.
Sign-up for BioCryst Reports Fourth Quarter & Full Year 2014 Financial Results investment picks
2015/2/18
Sapiens IDIT system to replace legacy environment with modern technology and capabilities to enable process and cost efficiencies, and speed time to market HOLON, Israel , February 18, 2015 /PRNewswire/ -- Sapiens International Corporation , (NASDAQ and TASE: SPNS), a leading global provider of software solutions for the insurance industry, with an emerging focus on the broader financial services sector, announced today that Tradex Insurance Company Ltd.
Sign-up for Tradex Selects Sapiens P&C Software Suite to Support All Motor Trade Lines of Business investment picks
2015/2/18
Total revenue up 23.7% y/y; North America product revenue up 50.2% y/y Generated $13.3 million in cash from operations Successful commercial launches of UltraShape and PicoWay YOKNEAM, Israel , Feb.
Sign-up for Syneron Medical Reports Record Revenue of $74.1 Million for the Fourth Quarter 2014 investment picks
2015/2/18
TSO3 announces filing of preliminary short form prospectus Canada NewsWire Ticker: TSX – TOS Shares Outstanding: 73,399,656 /NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES / QUÉBEC CITY, Feb.
Sign-up for TSO3 announces filing of preliminary short form prospectus investment picks
2015/2/18
New UltraShape Campaign Promises a Flatter Tummy Without Torture IRVINE, Calif.
Sign-up for Syneron Candela's Ultrashape Is Challenging Exercise To Eliminate Stubborn Fat investment picks
2015/2/18
BETHESDA, Md., Feb.
Sign-up for Sucampo Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2014 Earnings Call investment picks
2015/2/18
- 9 mid- to late-stage compounds in development - - Novel compounds in specialty and primary care markets with high unmet medical need - - Industry-leading productivity across generic pipeline - - More than 40 ANDAs filed in 2014; 25 Confirmed First-to-Files - DUBLIN , Feb.
Sign-up for Actavis Outlines Standalone Pharmaceutical Pipeline at Investor Meeting investment picks
2015/2/18
HOUSTON , Feb.
Sign-up for Columbia Pipeline Partners LP Reports Predecessor Fourth Quarter and Full-Year 2014 Results investment picks
2015/2/18
- Results exceed 2014 guidance range - Infrastructure investment, regulatory programs driving continued growth - Columbia Pipeline Partners IPO completed successfully - Separation remains on track for mid-2015 - Projected long-term growth rates highlighted for both NiSource and Columbia Pipeline Group MERRILLVILLE, Ind.
Sign-up for NiSource Reports 2014 Earnings investment picks
2015/2/18
Oncolytics Biotech® Inc. Announces Completion of Enrollment in Randomized Phase II Colorectal Cancer Study Canada NewsWire CALGARY , Feb.
Sign-up for Oncolytics Biotech® Inc. Announces Completion of Enrollment in Randomized Phase II Colorectal Cancer Study investment picks
2015/2/18
Leading U.S. toymaker JAKKS Pacific, Inc., (Nasdaq: JAKK) announced today that it has been granted rights to manufacture, market and distribute a line of consumer products based on the Minions from Universal Pictures and Illumination Entertainment’s Despicable Me global film franchise as well as their upcoming film Minions , in theaters July 10, 2015.
Sign-up for JAKKS Pacific Secures Licensing Agreement for Universal Pictures and Illumination Entertainment’s Despicable Me Franchise Including Their Upcoming Film Minions investment picks
2015/2/18
Integrated Device Technology, Inc. ( IDT ®) (NASDAQ:IDTI) announced today that it will showcase its leading wireless technology in early March at Mobile World Congress 2015 in Barcelona.
Sign-up for IDT Demonstrating Wireless Power and Wireless Infrastructure Solutions at Mobile World Congress 2015 investment picks
2015/2/18
ST. LOUIS, Feb.
Sign-up for Stereotaxis to Report Fourth Quarter and Full Year 2014 Financial Results on February 25, 2015 investment picks
2015/2/18
Cinemark Holdings, Inc. (NYSE: CNK), one of the largest motion picture exhibitors in the world, today reported results for the three months and year ended December 31, 2014.
Sign-up for Cinemark Holdings, Inc. Reports Revenues of $659.9 Million and Adjusted EBITDA of $156.9 Million for Q4 2014 investment picks
2015/2/18
Illumina, Inc. (NASDAQ:ILMN) today announced that it will webcast the Company’s presentation at the Cowen and Company 35th Annual Health Care Conference in Boston, Massachusetts, on March 4, 2015.
Sign-up for Illumina to Webcast Live Presentation at the Cowen and Company Annual Health Care Conference investment picks
2015/2/18
- Adjusted EBITDA Increases 80% to $1.5 Billion in Fourth Quarter 2014 - - $12.8 Billion Full Year Non-GAAP Net Revenue Increases 48% - - $4.5 Billion Full Year Adjusted EBITDA Increases 99% - - Exceptional Performance across Global Businesses - - GAAP Loss per Diluted Share in Fourth Quarter of $2.76 - - Standalone 2015 Forecast Raised to $16.30-$17.30 - DUBLIN , Feb.
Sign-up for Actavis Non-GAAP Net Revenue Increases 44% to $4 Billion in Fourth Quarter 2014; Non-GAAP EPS Increases 23% to $3.91; Increases 2015 Standalone Forecast investment picks
2015/2/18
NEW YORK, Feb.
Sign-up for Criteo Reports Record Results for the Fourth Quarter & Fiscal Year 2014 investment picks
2015/2/18
Hotel chain Hilton Worldwide Holdings Inc. (HLT) said on Wednesday that fourth-quarter profit rose to $158 million, or 16 cents a share, up from $26 million, or 3 cents a share, in the year-ago period.
Sign-up for Hilton profit jumps, but misses estimates slightly investment picks
2015/2/18
Allegion plc (NYSE: ALLE), a leading global provider of security products and solutions, today reported fourth-quarter 2014 net revenues of $573.5 million and net earnings of $35.6 million, or $0.37 per share from continuing operations.
Sign-up for Allegion Reports Year-End 2014 Financial Results and 2015 Outlook investment picks
2015/2/18
HOUSTON , Feb.
Sign-up for Harvest Natural Resources Receives Continued Notice Listing From NYSE investment picks
2015/2/18
Epsilon and Franklin Covey Co.
Sign-up for Epsilon and Franklin Covey Co. Presented 2014 Brandon Hall Excellence in Learning Silver Award for ‘Best Custom Content’ investment picks
2015/2/18
TORTOLA, BRITISH VIRGIN ISLANDS --
Sign-up for ATLAS Mara Limited: Notification of major interest in shares investment picks
2015/2/18
PLANO, Texas , Feb.
Sign-up for Doritos Unleashes Another Dimension Of Snacking With Doritos Jacked 3D investment picks
2015/2/18
SAN FRANCISCO, Feb.
Sign-up for CollabRx Regains Compliance on Bid Price investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: The Medicines Company Reports Fourth Quarter and Full Year 2014 Financial Results to CollabRx Regains Compliance on Bid Price
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent